{"entity":{"type":"insider","cik":"0001425391","url":"/insider/0001425391","json_url":"/insider/0001425391.json","name":"Presidio Partners 2007 GP, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":2,"first":"2016-04-15","last":"2016-04-20","span_basis":"filed_date"},"name_variants":[{"name":"Presidio Partners 2007 GP, LLC","source":"filing","n_filings":2,"first_seen":"2016-04-15","last_seen":"2016-04-20"}],"transactions":[{"id":2248030,"accession":"0001209191-16-115074","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-115074","line_url":"/filing/0001209191-16-115074","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 GP, L.P.; Watson James F; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007, L.P.","owner_display_name":"Presidio Partners 2007 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8540.0,"shares_display":"8,540","price_per_share":9.8841,"price_display":"9.88","price_state":"stated","total_value":84410.214,"total_display":"84,410.21","total_whole":"84,410","shares_owned_after":1559995.0,"shares_owned_after_display":"1,559,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-20","filed_date":"2016-04-20","scope":"insider","n_lines":2},{"id":2248020,"accession":"0001209191-16-115074","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-115074","line_url":"/filing/0001209191-16-115074","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 GP, L.P.; Watson James F; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007, L.P.","owner_display_name":"Presidio Partners 2007 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7279.0,"shares_display":"7,279","price_per_share":10.029,"price_display":"10.03","price_state":"stated","total_value":73001.091,"total_display":"73,001.09","total_whole":"73,001","shares_owned_after":1568322.0,"shares_owned_after_display":"1,568,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-19","filed_date":"2016-04-20","scope":"insider","n_lines":2},{"id":2248009,"accession":"0001209191-16-115074","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-115074","line_url":"/filing/0001209191-16-115074","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 GP, L.P.; Watson James F; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007, L.P.","owner_display_name":"Presidio Partners 2007 GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4548.0,"shares_display":"4,548","price_per_share":10.0996,"price_display":"10.10","price_state":"stated","total_value":45932.9808,"total_display":"45,932.98","total_whole":"45,933","shares_owned_after":1575419.0,"shares_owned_after_display":"1,575,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-18","filed_date":"2016-04-20","scope":"insider","n_lines":2},{"id":3352690,"accession":"0001209191-16-114436","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-16-114436","line_url":"/filing/0001209191-16-114436","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007 GP, L.P.; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007, L.P.; Watson James F","owner_display_name":"Presidio Partners 2007 (Parallel), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18210.0,"shares_display":"18,210","price_per_share":10.201453871499176,"price_display":"10.20","price_state":"stated","total_value":185768.475,"total_display":"185,768.48","total_whole":"185,768","shares_owned_after":1586873.0,"shares_owned_after_display":"1,586,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-15","filed_date":"2016-04-15","scope":"insider","n_lines":4},{"id":3352682,"accession":"0001209191-16-114436","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-16-114436","line_url":"/filing/0001209191-16-114436","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007 GP, L.P.; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007, L.P.; Watson James F","owner_display_name":"Presidio Partners 2007 (Parallel), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27066.0,"shares_display":"27,066","price_per_share":10.291331892411144,"price_display":"10.29","price_state":"stated","total_value":278545.189,"total_display":"278,545.19","total_whole":"278,545","shares_owned_after":1610283.0,"shares_owned_after_display":"1,610,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-14","filed_date":"2016-04-15","scope":"insider","n_lines":4},{"id":3352670,"accession":"0001209191-16-114436","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-114436","line_url":"/filing/0001209191-16-114436","is_derivative":false,"issuer_cik":"0001340886","issuer_name":"Neos Therapeutics, Inc.","issuer_ticker":"NEOS","issuer_name_source":null,"issuer_url":"/issuer/0001340886","owner_cik":null,"owner_name":"Presidio Partners 2007 (Parallel), L.P.; Presidio Partners 2007 GP, L.P.; Sohail Faysal A.; Presidio Partners 2007 GP, LLC; Collier David J; Presidio Partners 2007, L.P.; Watson James F","owner_display_name":"Presidio Partners 2007 (Parallel), L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12692.0,"shares_display":"12,692","price_per_share":10.1619,"price_display":"10.16","price_state":"stated","total_value":128974.8348,"total_display":"128,974.83","total_whole":"128,975","shares_owned_after":1623997.0,"shares_owned_after_display":"1,623,997","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-13","filed_date":"2016-04-15","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001467652","name":"Neos Therapeutics, Inc.","url":"/issuer/0001467652","role":"Ten percent owner","n_filings":2,"first_seen":"2016-04-15","last_seen":"2016-04-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001425391","retrieved_at":"2026-08-23T08:30:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}